ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 558,72
0,55%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Juno Therapeutics, Inc. (delisted) (JUNO)

  7. Juno Therapeutics, Inc. (delisted) (JUNO) Actualités

JUNO

JUNO THERAPEUTICS, INC. (JUNO)

Juno Therapeutics, Inc. (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:JUNO
DateHeureSourceTitreSymboleSociété
14/02/201912h43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
16/04/201822h08Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
16/03/201813h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
08/03/201800h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
06/03/201814h33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
06/03/201814h24Edgar (US Regulatory)(25-NSE)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
06/03/201814h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
06/03/201814h02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
05/03/201814h19Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
05/03/201814h13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
05/03/201814h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
05/03/201814h02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
01/03/201822h17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
21/02/201813h30Business WireCelgene Receives Antitrust Clearance for Juno AcquisitionNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
14/02/201812h53Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
02/02/201822h50Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
02/02/201822h44Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
02/02/201822h38Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
29/01/201823h30Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
25/01/201821h33Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
24/01/201818h40PR Newswire (US)WeissLaw LLP Investigates Juno Therapeutics Inc. AcquisitionNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
23/01/201809h02Dow Jones NewsDrug Firms Bet Billions on Biotech -- WSJNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
23/01/201802h00Dow Jones NewsBig Drugmakers Pay Big Prices for Promising Biotechs -- UpdateNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201820h13Dow Jones NewsBig Drugmakers Pay Big Prices for Promising BiotechsNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201817h51PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Juno Therapeutics, Inc.NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201817h19Dow Jones NewsCelgene to Buy Juno Therapeutics for $9 Billion -- 2nd UpdateNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201814h49PR Newswire (US)Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.NASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201813h59Dow Jones NewsCelgene to Buy Juno Therapeutics for $9 Billion -- UpdateNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201813h19Dow Jones NewsCelgene to Buy Juno Therapeutics For $9 BillionNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
22/01/201812h30Business WireCelgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular ImmunotherapyNASDAQ:JUNOJuno Therapeutics, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:JUNO

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
EU
AF
Air FranceKLM
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
RNO
Renault
EU
BN
Danone
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
EU
MC
Lvmh Moet Hennessy Louis...
EU
BEL20
Bel 20
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés